522,109 Shares in Astrana Health, Inc. (NASDAQ:ASTH) Purchased by Loomis Sayles & Co. L P

Loomis Sayles & Co. L P acquired a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) in the 3rd quarter, HoldingsChannel reports. The firm acquired 522,109 shares of the company’s stock, valued at approximately $30,251,000.

A number of other hedge funds also recently added to or reduced their stakes in ASTH. Charles Schwab Investment Management Inc. acquired a new stake in shares of Astrana Health in the 3rd quarter valued at approximately $25,945,000. Intech Investment Management LLC acquired a new stake in Astrana Health in the third quarter valued at $874,000. Moran Wealth Management LLC acquired a new stake in Astrana Health in the third quarter valued at $379,000. Premier Fund Managers Ltd purchased a new stake in Astrana Health during the third quarter worth about $918,000. Finally, Quest Partners LLC acquired a new position in Astrana Health during the third quarter worth about $133,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on ASTH. TD Cowen initiated coverage on Astrana Health in a report on Monday, October 14th. They set a “buy” rating and a $66.00 price objective for the company. Truist Financial boosted their price objective on shares of Astrana Health from $50.00 to $59.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. Stifel Nicolaus lifted their target price on shares of Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. Robert W. Baird raised their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. Finally, BTIG Research upped their target price on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. One analyst has rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $65.17.

Astrana Health Stock Performance

Astrana Health stock opened at $42.40 on Tuesday. The stock has a fifty day moving average price of $54.17 and a 200 day moving average price of $47.94. Astrana Health, Inc. has a 52 week low of $32.32 and a 52 week high of $63.20. The firm has a market capitalization of $2.39 billion, a P/E ratio of 32.62, a PEG ratio of 1.95 and a beta of 1.24. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.33 EPS for the quarter, meeting analysts’ consensus estimates of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The company had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. During the same quarter in the prior year, the company posted $0.47 EPS. Equities research analysts anticipate that Astrana Health, Inc. will post 1.17 earnings per share for the current year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.